Literature DB >> 9773112

[Investigation on self-medication: from disease to performance].

P Laure.   

Abstract

UNLABELLED: Self-medication is widely practised and could be defined as taking drugs without the advice of a physician. The present survey documented self-medication users' profile and their drug-taking behaviour. EXPERIMENTAL
DESIGN: prospective study by self-report questionnaire. PARTICIPANTS: 600 residents of the Meurthe et Moselle subdivision (eastern France), ranging in age from 15 to 85 years, including 288 males and 312 females. MEASURES: use and impressions of self-medication, based on the subjects' own experience. DATA ANALYSIS: questionnaires were coded and put on computer. The data were analysed and compared by chi-square and analysis of variance. Statistical significance was accepted at p < 0.05.
RESULTS: 313 subjects (52.2 per cent) reported having used self-medication. The three main motives for this practice were: headache (46.9 per cent), nose, throat or respiratory tract diseases (22.1 per cent) and abdominal pain (7.3 per cent). Self-use of drugs usually involved left-over past prescribed treatment (76 per cent), or were bought without the advice of a pharmacist (28 per cent). The self-medication user tends to be a woman, ranging in age from 20 to 39 years, living in a marital relationship and resident in an urban zone. The behaviours leading to self-medication were studied. Five groups are described, probably associated with five different attitudes towards self-medication. One of them shows subjects who essentially use drugs not to treat a disease but to enhance their performance.

Entities:  

Mesh:

Year:  1998        PMID: 9773112

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  1 in total

1.  Predisposing factors to the practice of self-medication in Brazil: Results from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM).

Authors:  Emilia da Silva Pons; Daniela Riva Knauth; Álvaro Vigo; Sotero Serrate Mengue
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.